ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 170 filers reported holding ASCENDIS PHARMA A/S in Q3 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $169 | +4.3% | 1,810 | 0.0% | 0.01% | +16.7% |
| Q2 2023 | $162 | -16.5% | 1,810 | 0.0% | 0.01% | -7.7% |
| Q1 2023 | $194 | -37.2% | 1,810 | -28.4% | 0.01% | -35.0% |
| Q4 2022 | $309 | -99.9% | 2,528 | +26.3% | 0.02% | +42.9% |
| Q3 2022 | $207,000 | +54.5% | 2,002 | +39.2% | 0.01% | +75.0% |
| Q2 2022 | $134,000 | +415.4% | 1,438 | +550.7% | 0.01% | +700.0% |
| Q1 2022 | $26,000 | -82.6% | 221 | -80.0% | 0.00% | -85.7% |
| Q4 2021 | $149,000 | -68.0% | 1,104 | -62.2% | 0.01% | -65.0% |
| Q3 2021 | $465,000 | -13.1% | 2,920 | -28.2% | 0.02% | -4.8% |
| Q2 2021 | $535,000 | +31.1% | 4,069 | +28.7% | 0.02% | +23.5% |
| Q1 2021 | $408,000 | +4.9% | 3,162 | +35.5% | 0.02% | 0.0% |
| Q4 2020 | $389,000 | +2.9% | 2,334 | -4.8% | 0.02% | -10.5% |
| Q3 2020 | $378,000 | +13.5% | 2,451 | +9.0% | 0.02% | -9.5% |
| Q2 2020 | $333,000 | +75.3% | 2,249 | +33.0% | 0.02% | +40.0% |
| Q1 2020 | $190,000 | -23.7% | 1,691 | -5.4% | 0.02% | 0.0% |
| Q4 2019 | $249,000 | +43.1% | 1,787 | -1.3% | 0.02% | +36.4% |
| Q3 2019 | $174,000 | +10.8% | 1,810 | +32.7% | 0.01% | +22.2% |
| Q2 2019 | $157,000 | – | 1,364 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,225,357 | $1,001,863,112 | 18.92% |
| Q Global Advisors, LLC | 195,000 | $17,404 | 12.55% |
| Sofinnova Investments, Inc. | 754,032 | $67,297,356 | 4.41% |
| Avoro Capital Advisors LLC | 3,580,555 | $319,564,534 | 4.34% |
| Finepoint Capital LP | 139,772 | $12,474,651 | 4.32% |
| Spyglass Capital Management LLC | 657,853 | $58,713,380 | 4.24% |
| Saturn V Capital Management LP | 78,442 | $7,000,948 | 3.88% |
| DAFNA Capital Management LLC | 135,212 | $12,067,671 | 3.30% |
| ARS Investment Partners, LLC | 289,860 | $25,870,005 | 3.02% |
| Ghost Tree Capital, LLC | 100,000 | $8,925,000 | 2.95% |